Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: IgA Nephropathy Biomarkers Evaluation Study (INTEREST)

View source ↗

Summary

An ongoing biomarker evaluation study for IgA nephropathy and other glomerular diseases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-sen University | Conditions: IgA Nephropathy, Glomerular Diseases | Status: RECRUITING